Discount for SOLACI Members – V Heart Failure Review 2020

On December 7 thru 12 SOLACI is holding the 5th International Round of Conferences 2020 on “Heart Failure and Pulmonary Hypertension: Management of hear failure in times of polypharmacy and artificial devices”.  

The event will take place next week Monday thru Friday from 5 to 7 pm and Saturday 12 from 10 to 12 am (Argentinian time).

SOLACI members interested in participating will have a 20% registration discount.

To access this benefit, write to webservices@solaci.org with the subject “V Heart Failure 2020 SOLACI Discount”, indicating full name and specialty. We will reply with a discount code to be entered to the event’s page upon registration. 

Here is the event flyer:


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

2025 SOLACI Research Grant

By initiative of the board of directors (together with the research department), SOLACI is launching a research grant aimed at improving knowledge and access...

New Virtual Event from CHIP LATAM SOLACI: Mexico Chapter

The Latin American Society of Interventional Cardiology invites you to participate in a new educational activity organized by the Department of Complex Percutaneous Coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...